JD Health repurchases 1.91 million shares for HKD 81.85 million; cumulative buy-back equals 0.066% of share capital

Bulletin Express05-18 21:43

JD Health International Inc. disclosed on 18 May 2026 that it bought back 1.91 million ordinary shares on the Hong Kong Stock Exchange. The repurchase was executed at prices ranging from HKD 42.46 to HKD 43.36 per share, translating to a volume-weighted average cost of HKD 42.89 and an aggregate consideration of HKD 81.85 million.

All shares acquired on 18 May, together with 198,050 shares repurchased on 15 May, are earmarked for cancellation. In total, 2.11 million shares are awaiting cancellation, equivalent to 0.066% of JD Health’s issued share capital of 3.21 billion shares.

The purchases were made under the general mandate approved on 20 June 2025, which authorises JD Health to repurchase up to 320.01 million shares. Following the latest transaction, the company has utilised approximately 0.66% of the mandate’s share limit. A 30-day moratorium on new share issues or treasury-share sales remains in force until 17 June 2026, as required under Hong Kong listing rules.

Apart from the repurchases, JD Health reported no other changes to its issued share capital and holds no treasury shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153807252?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153807252","market":"hk","top_or_hot":-1,"title":"JD Health repurchases 1.91 million shares for HKD 81.85 million; cumulative buy-back equals 0.066% of share capital","media":"Bulletin Express","content":"<p>JD Health International Inc. disclosed on 18 May 2026 that it bought back 1.91 million ordinary shares on the Hong Kong Stock Exchange. The repurchase was executed at prices ranging from HKD 42.46 to HKD 43.36 per share, translating to a volume-weighted average cost of HKD 42.89 and an aggregate consideration of HKD 81.85 million.</p>\n<p>All shares acquired on 18 May, together with 198,050 shares repurchased on 15 May, are earmarked for cancellation. In total, 2.11 million shares are awaiting cancellation, equivalent to 0.066% of JD Health’s issued share capital of 3.21 billion shares.</p>\n<p>The purchases were made under the general mandate approved on 20 June 2025, which authorises JD Health to repurchase up to 320.01 million shares. Following the latest transaction, the company has utilised approximately 0.66% of the mandate’s share limit. A 30-day moratorium on new share issues or treasury-share sales remains in force until 17 June 2026, as required under Hong Kong listing rules.</p>\n<p>Apart from the repurchases, JD Health reported no other changes to its issued share capital and holds no treasury shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health repurchases 1.91 million shares for HKD 81.85 million; cumulative buy-back equals 0.066% of share capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health repurchases 1.91 million shares for HKD 81.85 million; cumulative buy-back equals 0.066% of share capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-18 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. disclosed on 18 May 2026 that it bought back 1.91 million ordinary shares on the Hong Kong Stock Exchange. The repurchase was executed at prices ranging from HKD 42.46 to HKD 43.36 per share, translating to a volume-weighted average cost of HKD 42.89 and an aggregate consideration of HKD 81.85 million.</p>\n<p>All shares acquired on 18 May, together with 198,050 shares repurchased on 15 May, are earmarked for cancellation. In total, 2.11 million shares are awaiting cancellation, equivalent to 0.066% of JD Health’s issued share capital of 3.21 billion shares.</p>\n<p>The purchases were made under the general mandate approved on 20 June 2025, which authorises JD Health to repurchase up to 320.01 million shares. Following the latest transaction, the company has utilised approximately 0.66% of the mandate’s share limit. A 30-day moratorium on new share issues or treasury-share sales remains in force until 17 June 2026, as required under Hong Kong listing rules.</p>\n<p>Apart from the repurchases, JD Health reported no other changes to its issued share capital and holds no treasury shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1153807252","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153807252","pubTimestamp":1779111804,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. disclosed on 18 May 2026 that it bought back 1.91 million ordinary shares on the Hong Kong Stock Exchange. The repurchase was executed at prices ranging from HKD 42.46 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康8185万港元回购191万股；累计回购相当于股本的0.066%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. disclosed on 18 May 2026 that it bought back 1.91 million ordinary shares on the Hong Kong Stock Exchange. The repurchase was executed at prices ranging from HKD 42.46 to HKD 43.36 per share, translating to a volume-weighted average cost of HKD 42.89 and an aggregate consideration of HKD 81.85 million.\nAll shares acquired on 18 May, together with 198,050 shares repurchased on 15 May, are earmarked for cancellation. In total, 2.11 million shares are awaiting cancellation, equivalent to 0.066% of JD Health’s issued share capital of 3.21 billion shares.\nThe purchases were made under the general mandate approved on 20 June 2025, which authorises JD Health to repurchase up to 320.01 million shares. Following the latest transaction, the company has utilised approximately 0.66% of the mandate’s share limit. A 30-day moratorium on new share issues or treasury-share sales remains in force until 17 June 2026, as required under Hong Kong listing rules.\nApart from the repurchases, JD Health reported no other changes to its issued share capital and holds no treasury shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153807252","isCrawlerRequest":true}